Loading…
Lysozyme-Mediated Formation of Protein-Silica Nano-Composites for Biosensing Applications (Postprint)
We demonstrate a rapid method for enzyme immobilization directly on a waveguide surface by encapsulation in a silica matrix. Organophosphate hydrolase (OPH), an enzyme that catalytically hydrolyzes organophosphates, was used as a model enzyme to demonstrate the utility of lysozyme-mediated silica fo...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Report |
Language: | English |
Subjects: | |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | We demonstrate a rapid method for enzyme immobilization directly on a waveguide surface by encapsulation in a silica matrix. Organophosphate hydrolase (OPH), an enzyme that catalytically hydrolyzes organophosphates, was used as a model enzyme to demonstrate the utility of lysozyme-mediated silica formation for enzyme stabilization. Silica morphology and the efficiency of OPH encapsulation were directly influenced by the precursor choice used in silica formation. Covalent attachment of the lysozyme template directly to the waveguide surface provided a stable basis for silica formation and significantly increased the surface area for OPH encapsulation. OPH conjugated to a pH-responsive fluorophore was encapsulated in silica and patterned to a waveguide surface to demonstrate the immobilization strategy for the development of an organophosphate array biodetector. Silica-encapsulated OPH retained its catalytic activity for nearly 60 days with a detection limit of paraoxon of 35 microM. The encapsulation technique provides a potentially versatile tool with specific application to biosensor development.
Document contains color images. Published in Colloids and Surfaces B: Biointerfaces, v73 p58-64, 2009. Sponsored in part by USAF SG approved Clinical Investigation grant no. FDG20060049N and USAF CRADA grant no. 08-272-60MDG-CRADA01, and by the USDA-CSREES under grant no. 2006-34394-16953. Prepared in cooperation with Universal Technology Corporation, Dayton, OH, National Center of Biotechnology of the Republic of Kazakhstan, Astana, Kazakhstan, Texas A&M University, College Station, TX, Air Force Research Laboratory, Tyndall AFB, FL, Clinical Research Facility, 81st Medical Group, Keesler AFB, MS. |
---|